<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The purpose of this study was to assess whether the prevalence of inducible <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">myocardial ischemia</z:e> increases over time in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: Participants enrolled in the Detection of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischemia</z:e> in Asymptomatic Diabetics (DIAD) study underwent repeat <z:chebi fb="3" ids="16335">adenosine</z:chebi>-stress myocardial perfusion imaging 3 years after initial evaluation </plain></SENT>
<SENT sid="2" pm="."><plain>Patients with intervening cardiac events or revascularization and those who were unable or unwilling to repeat stress imaging were excluded </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Of the initial 522 DIAD patients, 358 had repeat stress imaging (DIAD-2), of whom 71 (20%) had <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> at enrollment (DIAD-1) </plain></SENT>
<SENT sid="4" pm="."><plain>Of 287 patients with <z:mpath ids='MPATH_458'>normal</z:mpath> DIAD-1 studies, 259 (90%) remained <z:mpath ids='MPATH_458'>normal</z:mpath> in DIAD-2, whereas 28 (10%) developed new <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in DIAD-2 </plain></SENT>
<SENT sid="5" pm="."><plain>Of the 71 patients with abnormal DIAD-1 studies, 56 (79%) demonstrated resolution of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, whereas 15 (21%) remained abnormal </plain></SENT>
<SENT sid="6" pm="."><plain>During this 3-year interval, medical treatment was intensified, with more patients using <z:chebi fb="0" ids="35664">statins</z:chebi>, aspirin, and <z:chebi fb="2" ids="35457">ACE inhibitors</z:chebi> than at baseline </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with resolution of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> had significantly greater increases in these medications than patients who developed new <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (P = 0.04) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Thus, the majority of asymptomatic patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> demonstrated resolution of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> upon repeat stress imaging after 3 years </plain></SENT>
<SENT sid="9" pm="."><plain>This resolution was associated with more intensive treatment of <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> </plain></SENT>
</text></document>